Inducing endogenous antimicrobial peptides to battle infections.
Zasloff
Michael
M
Departments of Surgery and Pediatrics, Georgetown University School of Medicine, Washington, DC 20007, USA. maz5@georgetown.edu
D000818:Animals; D000890:Anti-Infective Agents / Q000378:metabolism*; D023181:Antimicrobial Cationic Peptides / Q000378:metabolism*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000378:metabolism; D002087:Butyrates / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004405:Dysentery, Bacillary / Q000188:drug therapy* / Q000378:metabolism / Q000382:microbiology; D004847:Epithelial Cells / Q000378:metabolism; D006801:Humans; D007413:Intestinal Mucosa / Q000166:cytology / Q000378:metabolism; D012760:Shigella / Q000187:drug effects / Q000472:pathogenicity; D014807:Vitamin D / Q000627:therapeutic use; D054804:Cathelicidins
D000890:Anti-Infective Agents; D023181:Antimicrobial Cationic Peptides; D002087:Butyrates; D014807:Vitamin D; D054804:Cathelicidins